These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 22388515)

  • 1. Molecular pathways: fibroblast growth factor signaling: a new therapeutic opportunity in cancer.
    Brooks AN; Kilgour E; Smith PD
    Clin Cancer Res; 2012 Apr; 18(7):1855-62. PubMed ID: 22388515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of fibroblast growth factors and their receptors in prostate cancer.
    Kwabi-Addo B; Ozen M; Ittmann M
    Endocr Relat Cancer; 2004 Dec; 11(4):709-24. PubMed ID: 15613447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast growth factor receptor inhibitors as a cancer treatment: from a biologic rationale to medical perspectives.
    Dieci MV; Arnedos M; Andre F; Soria JC
    Cancer Discov; 2013 Mar; 3(3):264-79. PubMed ID: 23418312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De-regulated FGF receptors as therapeutic targets in cancer.
    Knights V; Cook SJ
    Pharmacol Ther; 2010 Jan; 125(1):105-17. PubMed ID: 19874848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of fibroblast growth factor signal pathway inhibits the growth of synovial sarcomas: potential application of signal inhibitors to molecular target therapy.
    Ishibe T; Nakayama T; Okamoto T; Aoyama T; Nishijo K; Shibata KR; Shima Y; Nagayama S; Katagiri T; Nakamura Y; Nakamura T; Toguchida J
    Clin Cancer Res; 2005 Apr; 11(7):2702-12. PubMed ID: 15814652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FGF/FGFR signaling in bone formation: progress and perspectives.
    Marie PJ; Miraoui H; Sévère N
    Growth Factors; 2012 Apr; 30(2):117-23. PubMed ID: 22292523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small molecule inhibition of fibroblast growth factor receptors in cancer.
    Liang G; Chen G; Wei X; Zhao Y; Li X
    Cytokine Growth Factor Rev; 2013 Oct; 24(5):467-75. PubMed ID: 23830577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of fibroblast growth factor-8 and its cognate receptors, fibroblast growth factor receptor (FGFR)-3c and-4, in fetal bovine preantral follicles.
    Buratini J; Glapinski VF; Giometti IC; Teixeira AB; Costa IB; Avellar MC; Barros CM; Price CA
    Mol Reprod Dev; 2005 Mar; 70(3):255-61. PubMed ID: 15625702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro biological characterization and antiangiogenic effects of PD 166866, a selective inhibitor of the FGF-1 receptor tyrosine kinase.
    Panek RL; Lu GH; Dahring TK; Batley BL; Connolly C; Hamby JM; Brown KJ
    J Pharmacol Exp Ther; 1998 Jul; 286(1):569-77. PubMed ID: 9655904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FGF signaling network in the gastrointestinal tract (review).
    Katoh M; Katoh M
    Int J Oncol; 2006 Jul; 29(1):163-8. PubMed ID: 16773196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of fibroblast growth factor/fibroblast growth factor receptor activity in glioma cells impedes tumor growth by both angiogenesis-dependent and -independent mechanisms.
    Auguste P; Gürsel DB; Lemière S; Reimers D; Cuevas P; Carceller F; Di Santo JP; Bikfalvi A
    Cancer Res; 2001 Feb; 61(4):1717-26. PubMed ID: 11245488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast growth factor signaling controlling bone formation: an update.
    Marie PJ
    Gene; 2012 Apr; 498(1):1-4. PubMed ID: 22342254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FGF and FGFR signaling in chondrodysplasias and craniosynostosis.
    Marie PJ; Coffin JD; Hurley MM
    J Cell Biochem; 2005 Dec; 96(5):888-96. PubMed ID: 16149058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of vascular development by fibroblast growth factors.
    Auguste P; Javerzat S; Bikfalvi A
    Cell Tissue Res; 2003 Oct; 314(1):157-66. PubMed ID: 12851809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced invasion and tumor growth of fibroblast growth factor 8b-overexpressing MCF-7 human breast cancer cells.
    Ruohola JK; Viitanen TP; Valve EM; Seppänen JA; Loponen NT; Keskitalo JJ; Lakkakorpi PT; Härkönen PL
    Cancer Res; 2001 May; 61(10):4229-37. PubMed ID: 11358849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brivanib alaninate, a dual inhibitor of vascular endothelial growth factor receptor and fibroblast growth factor receptor tyrosine kinases, induces growth inhibition in mouse models of human hepatocellular carcinoma.
    Huynh H; Ngo VC; Fargnoli J; Ayers M; Soo KC; Koong HN; Thng CH; Ong HS; Chung A; Chow P; Pollock P; Byron S; Tran E
    Clin Cancer Res; 2008 Oct; 14(19):6146-53. PubMed ID: 18829493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast growth factor signaling in Caenorhabditis elegans.
    Borland CZ; Schutzman JL; Stern MJ
    Bioessays; 2001 Dec; 23(12):1120-30. PubMed ID: 11746231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotactic migration of mesencephalic neural crest cells in the mouse.
    Kubota Y; Ito K
    Dev Dyn; 2000 Feb; 217(2):170-9. PubMed ID: 10706141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting fibroblast growth factor receptors blocks PI3K/AKT signaling, induces apoptosis, and impairs mammary tumor outgrowth and metastasis.
    Dey JH; Bianchi F; Voshol J; Bonenfant D; Oakeley EJ; Hynes NE
    Cancer Res; 2010 May; 70(10):4151-62. PubMed ID: 20460524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AZD4547: an orally bioavailable, potent, and selective inhibitor of the fibroblast growth factor receptor tyrosine kinase family.
    Gavine PR; Mooney L; Kilgour E; Thomas AP; Al-Kadhimi K; Beck S; Rooney C; Coleman T; Baker D; Mellor MJ; Brooks AN; Klinowska T
    Cancer Res; 2012 Apr; 72(8):2045-56. PubMed ID: 22369928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.